Noted for its expertise in food and therapeutic goods regulations, Ashurst is a key port of call for a litany of blue-chip clients on portfolio protection and enforcement. With over two decades of experience, head of the practice Anita Cade is well-equipped to handle intellectual property litigation as well as licensing and transactional mandates. Lisa Ritson is experienced in contentious consumer protection, marketing, and trade mark matters. Stuart D’Aloisio in Melbourne assists life sciences clients with patent infringements, validity issues and litigation, while Nina Fitzgerald is knowledgeable of alternative dispute resolution concerning copyright, patents, and domestic consumer law. All of the individuals that have been mentioned are located in Sydney, unless stated otherwise.
Testimonials
Collated independently by Legal 500 research team.
- ‘They have a terrific team, with a depth of scientific knowledge.’
- ‘The team can draw on its national capabilities to offer seamless and top tier support.'
- ‘Smart, experienced, and commercial in IP litigation. They have a leading number of female leaders.’
- ‘The Ashurst team is very competent and reliable.’
- ‘Stuart D'Aloisio is very conscientious, incisive and always across the detail. Nina Fitzgerald is excellent at managing her matters.’
- ‘Lisa Ritson has a wealth of expertise and impeccable judgement.’
- ‘Anita Cade is a stellar IP partner - she is accessible, superbly knowledgeable, practical and has in-depth knowledge and experience.’
- ‘Anita Cade is knowledgeable, has excellent people skills, a good understanding of clients' best interests, and is an experienced litigator who thinks outside the box.’
Key clients
- AGL Energy Limited
- ANZ Banking Group
- Boehringer Ingelheim Animal Health
- Combe International
- Crown Resorts
- Henkel
- Henley Arch
- Peloton
- Pharmacor
- Samsung Bioepis
- Toll Holdings
- Woolworths
Work highlights
- Acting for Samsung Bioepis in proceedings against Pfizer before the Federal Court of Australia relating to BRENZYS which is Samsung Bioepis' biosimilar for Pfizer's biological drug ENBREL.
- Acting for Henley Arch against Henley Constructions in trade mark infringement, misleading, and deceptive conduct proceedings in the Federal Court concerning the use of the HENLEY trade mark.
- Representing Peloton Interactive in the Federal Court of Australia on the basis that Mad Dogg's SPINNING marks should be removed from the register as it is a generic term.
Lawyers
Practice head
The lawyer(s) leading their teams.
Anita Cade